Virtual Clinical Trials Market Size, Share & Trends Report

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-239-7
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                 1.1. Market Segmentation & Scope
                      1.1.1. Study design
                      1.1.2. Indication
                      1.1.3. Regional scope
                      1.1.4. Estimates and forecast timeline
                 1.2. Research Methodology
                 1.3. Information Procurement
                      1.3.1. Purchased database
                      1.3.2. GVR’s internal database
                      1.3.3. Secondary sources
                      1.3.4. Primary research
                 1.4. Information or Data Analysis
                      1.4.1. Data analysis models
                 1.5. Market Formulation & Validation
                 1.6. Model Details
                      1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                 1.7. List of Secondary Sources
                 1.8. List of Primary Sources
                 1.9. Objectives
                      1.9.1. Objective 1: Understanding the market dynamics
                      1.9.2. Objective 2: Understanding the market estimates and forecasts
                      1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
                      1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
                 2.1. Market Outlook
                 2.2. Segment Outlook
                 2.3. Competitive Insights
Chapter 3. Virtual/Decentralized Clinical Trials Market Variables, Trends & Scope
                 3.1. Market Lineage outlook
                      3.1.1. Parent market outlook
                      3.1.2. Related/ancillary market outlook
                 3.2. Penetration & Growth Prospect Mapping
                 3.3. COVID-19 pandemic impact on clinical trial activity
                 3.4. Market Dynamics
                      3.4.1. Market Driver Analysis
                            3.4.1.1. The growing role technology in the healthcare
                            3.4.1.2. Benefits of virtual trials
                            3.4.1.3. Government support
                      3.4.2. Market Restraint Analysis
                            3.4.2.1. Data Security
                      3.4.3. Industry Challenge
                 3.5. Virtual/Decentralized Clinical Trials: Market Analysis Tools
                      3.5.1. Industry Analysis – Porter’s
                            3.5.1.1. Supplier Power
                            3.5.1.2. Buyer Power
                            3.5.1.3. Substitution Threat
                            3.5.1.4. Threat from new entrant
                            3.5.1.5. Competitive rivalry
                      3.5.2. PESTEL Analysis
Chapter 4. Virtual/Decentralized Clinical Trials Market: Segment Analysis, By Study Design, 2017 - 2030 (USD Million)
                 4.1. Segment Dashboard
                 4.2. Study Design Market Share Analysis, 2020 & 2030
                 4.3. Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 to 2030
                 4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                      4.4.1. Interventional
                      4.4.2. Observational
                      4.4.3. Expanded Access
Chapter 5. Virtual/Decentralized Clinical Trials Market: Segment Analysis, By Indication, 2017 - 2030 (USD Million)
                 5.1. Segment Dashboard
                 5.2. Indication Market Share Analysis, 2021 & 2030
                 5.3. Global Virtual/Decentralized Clinical Trials Market, By Indication, 2017 to 2030
                 5.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                     5.4.1. CNS
                     5.4.2. Autoimmune/Inflammation
                     5.4.3. Cardiovascular Disease
                     5.4.4. Metabolic/ Endocrinology
                     5.4.5. Infectious Disease
                     5.4.6. Oncology
                     5.4.7. Genitourinary
                     5.4.8. Ophthalmology
                     5.4.9. Others
Chapter 6. Virtual/Decentralized Clinical Trials Market: Segment Analysis, By Phase, 2017 - 2030 (USD Million)
                 6.1. Segment Dashboard
                 6.2. Indication Market Share Analysis, 2021 & 2030
                 6.3. Global Virtual/Decentralized Clinical Trials Market, By Phase, 2017 to 2030
                 6.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                     6.4.1. Phase I
                     6.4.2. Phase II
                     6.4.3. Phase III
                     6.4.4. Phase IV
Chapter 7. Virtual/Decentralized Clinical Trials Market: Regional Market Analysis, by Study Design, 2017 - 2030 (USD Million)
                 7.1. Regional Market Dashboard
                 7.2. Regional Market Share Analysis, 2021 & 2030
                 7.3. Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
                 7.4. North America
                     7.4.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
                     7.4.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                     7.4.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                     7.4.4. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.4.4. U.S.
                         7.4.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.4.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.4.4.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.4.5. Canada
                         7.4.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.4.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.4.5.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                 7.5. Europe
                     7.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
                     7.5.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                     7.5.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                     7.5.4. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.5.5. Germany
                         7.5.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.5.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.5.5.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.5.6. U.K.
                         7.5.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.5.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.5.6.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.5.7. France
                         7.5.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.5.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.5.7.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.5.8. Italy
                         7.5.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.5.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.5.8.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.5.9. Spain
                         7.5.9.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.5.9.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.5.9.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                 7.6. Asia Pacific
                     7.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
                     7.6.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                     7.6.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                     7.6.4. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.6.4. India
                         7.6.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.6.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.6.4.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.6.5. Japan
                         7.6.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.6.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.6.5.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.6.6. China
                         7.6.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.6.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.6.6.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.6.7. Australia
                         7.6.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.6.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.6.7.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.6.8. South Korea
                         7.6.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.6.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.6.8.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                 7.7. Latin America
                     7.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
                     7.7.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                     7.7.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                     7.7.4. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.7.5. Brazil
                         7.7.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.7.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.7.5.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.7.6. Mexico
                         7.7.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.7.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.7.6.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.7.7. Argentina
                         7.7.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.7.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.7.7.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.7.8. Colombia
                         7.7.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.7.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.7.8.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                 7.8. Middle East and Africa
                     7.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
                     7.8.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                     7.8.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                     7.8.4. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.8.5. South Africa
                         7.8.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.8.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.8.5.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.8.6. Saudi Arabia
                         7.8.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.8.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.8.6.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
                     7.8.7. UAE
                         7.8.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
                         7.8.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
                         7.7.7.3. Market estimates and forecast, by phase, 2017 - 2030 (USD Million)
Chapter 8. Virtual/Decentralized Clinical Trials Market– Competitive Analysis
                 8.1. Key companies profiled
                     8.1.1. ICON, plc
                         8.1.1.1. Company Overview
                         8.1.1.2. Financial Performance
                         8.1.1.3. Product Benchmarking
                         8.1.1.4. Strategic Initiatives
                     8.1.2. PAREXEL International Corporation
                         8.1.2.1. Company Overview
                         8.1.2.2. Financial Performance
                         8.1.2.3. Product Benchmarking
                         8.1.2.4. Strategic Initiatives
                     8.1.3. IQVIA
                         8.1.3.1. Company Overview
                         8.1.3.2. Financial Performance
                         8.1.3.3. Product Benchmarking
                         8.1.3.4. Strategic Initiatives
                     8.1.4. Covance
                         8.1.4.1. Company Overview
                         8.1.4.2. Financial Performance
                         8.1.4.3. Product Benchmarking
                         8.1.4.4. Strategic Initiatives
                     8.1.5. PRA Health Sciences
                         8.1.5.1. Company Overview
                         8.1.5.2. Financial Performance
                         8.1.5.3. Product Benchmarking
                         8.1.5.4. Strategic Initiatives
                     8.1.6. LEO Innovation Lab
                         8.1.6.1. Company Overview
                         8.1.6.2. Financial Performance
                         8.1.6.3. Product Benchmarking
                         8.1.6.4. Strategic Initiatives
                     8.1.7. Medidata
                         8.1.7.1. Company Overview
                         8.1.7.2. Financial Performance
                         8.1.7.3. Product Benchmarking
                         8.1.7.4. Strategic Initiatives
                     8.1.8. Oracle
                         8.1.8.1. Company Overview
                         8.1.8.2. Financial Performance
                         8.1.8.3. Product Benchmarking
                         8.1.8.4. Strategic Initiatives
                     8.1.9. CRF Health
                         8.1.9.1. Company Overview
                         8.1.9.2. Financial Performance
                         8.1.9.3. Product Benchmarking
                         8.1.9.4. Strategic Initiatives
                     8.1.10. Clinical Ink
                         8.1.10.1. Company Overview
                         8.1.10.2. Financial Performance
                         8.1.10.3. Product Benchmarking
                         8.1.10.4. Strategic Initiatives
                     8.1.11. Medable Inc.
                         8.1.11.1. Company Overview
                         8.1.11.2. Financial Performance
                         8.1.11.3. Product Benchmarking
                         8.1.11.4. Strategic Initiatives
                     8.1.12. Signant Health
                         8.1.12.1. Company Overview
                         8.1.12.2. Financial Performance
                         8.1.12.3. Product Benchmarking
                         8.1.12.4. Strategic Initiatives
                     8.1.13. Halo Health Systems
                         8.1.13.1. Company Overview
                         8.1.13.2. Financial Performance
                         8.1.13.3. Product Benchmarking
                         8.1.13.4. Strategic Initiatives
                     8.1.14. Croprime
                         8.1.14.1. Company Overview
                         8.1.14.2. Financial Performance
                         8.1.14.3. Product Benchmarking
                         8.1.14.4. Strategic Initiatives


List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Virtual/decentralized clinical trials market: Market snapshot
Fig. 9 Virtual/decentralized clinical trials market: Market segmentation
Fig. 10 Virtual/decentralized clinical trials market strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Virtual/decentralized clinical trials market driver impact
Fig. 14 Virtual/decentralized clinical trials market restraint impact
Fig. 15 Virtual/decentralized clinical trials market porter’s five forces analysis
Fig. 16 Virtual/decentralized clinical trials market PESTEL analysis
Fig. 17 Virtual/decentralized clinical trials market: study design segment dashboard
Fig. 18 Virtual/decentralized clinical trials market: Study design movement analysis
Fig. 19 Interventional market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 20 Observational market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 21 Expanded Access market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 22 Virtual/decentralized clinical trials market: Segment dashboard
Fig. 23 Virtual/decentralized clinical trials market: Indication movement analysis
Fig. 24 Virtual/decentralized market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 25 CNS market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 26 Autoimmune/Inflammation market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 27 Cardiovascular Disease market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 28 Metabolic/Endocrinology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 29 Infectious Disease market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 30 Oncology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 Genitourinary market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Ophthalmology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 34 Virtual/decentralized clinical trials market: Phase movement analysis
Fig. 35 Virtual/decentralized market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Phase I market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 37 Phase II market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 38 Phase III market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 Phase IV market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 40 Global virtual/decentralized clinical trials market: Regional movement analysis
Fig. 41 Global virtual/decentralized clinical trials market: Regional outlook and key takeaways
Fig. 42 North America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Canada market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 45 Europe market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 46 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Germany market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 France market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 49 Italy market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 50 Spain market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 52 India market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 53 Japan market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 54 China market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 55 Australia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 56 South Korea market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 57 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 58 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 59 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 60 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 61 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 62 Middle East and Africa. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 63 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 64 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 65 UAE market estimates and forecast, 2017 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon